1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76. doi: 10.1016/j.cell.2006.07.024 .
2. Government of Japan. The Regenerative Medicine Promotion Act (the act regarding policy package to provide national citizens regenerative medicine timely and safely). 2013 Act No.13. [in Japanese].
3. Government of Japan. The Pharmaceuticals and Medical Devices Act (the act on securing quality, efficacy and safety of pharmaceuticals, medical devices, etc.). 1960 Act No. 145. [in Japanese].
4. Government of Japan. The Act on the Partial Revision of the Pharmaceutical Affairs Law. 2013 Act No.84. [in Japanese]. This act includes regulatory framework to secure quality, efficacy and safety of the regenerative medicine products.
5. Government of Japan. The Act on the Safety of Regenerative Medicine. 2013 Act No.85. [in Japanese]. This act covers regulation to secure safety of the regenerative medicine therapy provided under the responsibility of medical institutions.